ARTV ARTV
Company Profile ↓Company Overview
ARTV (ARTV) is a publicly traded company listed on with a market capitalization of $285.06M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.10.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -100.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -100.00% |
Stock Price Performance
| 1 Year: | +285.05% |
| 6 Months: | +179.95% |
| 3 Months: | +9.34% |
| 1 Month: | +22.26% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)65.30 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 3.50M | 26.66M | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | 22.17M | 22.81M | 22.90M | 21.93M | 24.43M |
| Operating Income | - | -11.82M | 10.81M | -14.49M | -16.19M | -18.34M | - | -22.17M | -22.81M | -22.90M | -21.93M | -24.43M |
| EBITDA | - | - | - | - | - | - | - | -21.54M | -22.17M | -22.23M | -21.27M | -23.76M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | -20.31M | -21.25M | -21.53M | -20.77M | -23.52M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -16.72M | -11.28M | 11.28M | -13.96M | -17.84M | -17.47M | - | -20.31M | -21.25M | -21.53M | -20.77M | -23.52M |
| Diluted EPS | - | -14.09 | 1.62 | -17.24 | -22.00 | -0.92 | - | -0.83 | -0.87 | -0.88 | - | -0.95 |
| R&D Expense | - | 11.26M | 13.06M | 11.16M | 12.33M | 13.52M | - | 17.05M | 17.86M | 17.63M | - | 19.31M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 32.92M | 251.00K | 0 |
| Operating Income | -30.67M | -67.28M | -89.81M |
| Net Income | -28.72M | -65.37M | -83.86M |
| Diluted EPS | -35.78 | -5.81 | -3.43 |
| R&D Expense | 50.25M | 50.33M | 69.54M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 133.05M | 105.11M | 209.58M | 130.94M |
| Current Assets | - | 104.67M | 79.82M | 188.63M | 112.67M |
| Cash & Equivalents | - | 102.53M | 53.50M | 40.23M | 26.70M |
| Inventory | - | - | - | - | - |
| Receivables | 468.00K | 525.00K | 1.03M | 0 | - |
| Total Liabilities | - | 273.75M | 267.13M | 22.94M | 20.97M |
| Current Liabilities | - | 25.62M | 12.23M | 12.25M | 13.09M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 19.45M | 16.91M | 14.35M | 10.94M |
| Total Equity | - | -140.70M | -162.01M | 186.64M | 109.97M |
| Shares Outstanding | - | 23.28M | 23.28M | 24.29M | 24.60M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -47.43M | -55.03M | -76.75M |
| Investing Cash Flow | -25.98M | -120.46M | 63.41M |
| Financing Cash Flow | 24.39M | 162.23M | 9.00K |
| Capital Expenditure | -3.26M | -642.00K | -2.59M |
| Free Cash Flow | -50.69M | -55.67M | -79.34M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | - | - | - |
| Operating Margin % | -93.2% | -26,805.6% | - |
| Net Margin % | -87.2% | -26,045.0% | - |
| ROE % | 17.7% | -35.0% | -76.3% |
| ROCE % | -33.0% | -34.1% | -76.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ARTV
Artiva Biotherapeutics (Nasdaq: ARTV) details 2026 meeting deadlines - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQbExRWWUtZkFkMGd6THJJc2FSd0UzREpDcWRqbzdINGFMd3BDLUdqZ0hfaVhjQ3NhbzlCb3JHMm5GUmtJelFKcGpwLUF2VTVWeUxMWm4tZTBPeGxoSjZpSGxQWEw1dWhXRFJuODVXUk9FZTh6MWtkQ1hoSWlPSkRrZlJ2NUV5Z0I3bkJ5RG…
ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE9zTks0M29OLXF2VG10VG1odzUyaGFhenFmdkRxTENvSER4SlNfTktoOHd5bVk1VndvMjVBNnNVSF9UX19DX19STWJ6R01acjMwMDZYWUdWRU5PUXBY?oc=5" target="_blank">ARTV Stock Price and Chart — NASDAQ:ARTV</a…
Is Artiva Biotherapeutics (NASDAQ:ARTV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQT1RvTmJ6bUtZTzdndWctZ1BjclZXUVVRak8wTUQxSWFKSHRHTGF5LXBYUXB0bEVVZ1ZBNVZjWWxaSWVQa2IxZTlSbl9iZHRJel9nRkFjR3cyZU4wREViQldxbk1UU0paWTEycE83S1dwX1kzQWlxNlktazZySXNLTl9NSERqYWNKeGl6Ql…
Ra capital management, 10% owner, acquires $455,725 Artiva stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxObjQtZGN4Z0NfUDQzeGFkbmxVQXRGSzE5NEJPTk5zV0hjektWNm1mVWRpSl80ZXJEVTVod2dFR21xbG9EWEdCVWZrTjVOZEU5cHV6eUFEejZVZ3ZjRkZTWVZUT1ZpXy11a1k3RFYzc2lZZzhhRm5OUkFHVFNFTUpJdjRRc1puMGRwdHI5M2…
$ARTV stock is up 13% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQNHR1ejVpeE9VMVFnQXhpaEtKSEQ5YlUtTHFrUlBWV0c1eWUyaXZrTEhDdlNHRWZ6dl85cllBeWR0Y1JneGR0MzJuYkEtMWpnbXV0YVdqYm1KQ0piUFJsNDFuZy1YUllwRVc1NFlzRDVrbmNDOXNXUkFxU0dDUV9NY1I4alAzMHVxc21hbn…
Artiva stock up on trial data for lead asset (ARTV:NASDAQ) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQTGFYaTdJUnJFakJjY21DMkpTZEJZeko2ZDJIT2FDR3lJU2NJNEFLcDNhQVdoY01uQ09TS25Cd0dHdHNFY2w5c2doWXpNenA3a0xrNEp6SlhGWnU0ck41Slk2YTV6QWJOY3liczlvVTRWeW15ZDVYTm5ZVnkwaHRYMg?oc=5" target="_…
ARTV — Frequently Asked Questions
What is the current share price of ARTV?
As of 2026-08-05 17:25 PDT, ARTV trades at $11.59 on NASDAQ/NYSE. Its 52-week range is $2.28 to $13.39.
What is the market capitalisation of ARTV?
ARTV has a market capitalisation of $285.06M on NASDAQ/NYSE.
What is the P/E ratio of ARTV?
ARTV trades at a trailing price-to-earnings (P/E) ratio of -3.38. Its price-to-book (P/B) ratio is 2.59.
What is the return on equity (ROE) of ARTV?
ARTV has a return on equity (ROE) of -76.26%. Its return on capital employed (ROCE) is -76.21%.
Is ARTV a good stock to buy?
This page provides a data-driven analysis of ARTV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.